Nilson (Ceftriaxone)

Ceftriaxone, the active ingredient in Nilson, is a third‑generation cephalosporin presented as an injection for intramuscular use. It treats serious bacterial infections such as pneumonia, meningitis, gonorrhea, urinary tract infections, and skin and soft‑tissue infections in adults and children. GNH USA supplies Nilson as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ceftriaxone is a broad‑spectrum cephalosporin used to treat infections caused by susceptible bacteria. - Community‑acquired pneumonia: provides effective bacterial clearance in lung tissue. - Meningitis: achieves high cerebrospinal fluid concentrations to eradicate meningococcal pathogens. - Gonorrhea: eliminates Neisseria gonorrhoeae in genital infections. - Urinary tract infections: resolves complicated UTIs caused by Gram‑negative organisms. - Skin and soft tissue infections: treats cellulitis and wound infections caused by susceptible strains.

Ceftriaxone may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Injection site pain or erythema: localized discomfort at the intramuscular site. - Diarrhea: mild to moderate loose stools. - Nausea or vomiting: gastrointestinal upset. - Elevated liver enzymes: transient increase in hepatic transaminases. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with airway compromise. - Clostridioides difficile colitis: severe diarrhea due to gut flora disruption. - Hemolytic anemia: immune‑mediated red cell destruction. - Gallbladder sludge or pseudolithiasis: biliary precipitation with prolonged use.

Ceftriaxone requires careful assessment of patient‑specific factors before use. - Renal impairment: monitor renal function and adjust dosing if needed. - Hepatic dysfunction: use with caution in patients with liver disease. - β‑lactam allergy: avoid in individuals with known cephalosporin or penicillin hypersensitivity. - Neonates and infants: watch for bilirubin displacement and kernicterus risk. - Pregnancy: risk unknown; prescribe only when benefits outweigh potential hazards. - Store at ambient temperature: keep in original container, protect from moisture and light.

Ceftriaxone can interact with several drugs, altering efficacy or safety.

Major Interactions (Avoid): - Calcium‑containing IV solutions: precipitate ceftriaxone, causing emboli. - Aminoglycosides: increased risk of nephrotoxicity when co‑administered. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect, requiring INR monitoring. - Live vaccines: reduced vaccine efficacy; avoid simultaneous administration.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate electrolyte disturbances. - Oral contraceptives: possible reduction in contraceptive effectiveness; advise backup method. - Probenecid: decreases renal clearance, increasing ceftriaxone levels.